相似文献
1
Research status and funding trends of lung cancer biomarkers.
J Thorac Dis. 2013 Oct;5(5):698-705. doi: 10.3978/j.issn.2072-1439.2013.10.10.
2
Clinical trials and biomarker research on lung cancer in China.
Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S45-50. doi: 10.1517/14728222.2011.630663. Epub 2012 Feb 7.
3
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Biomed Pharmacother. 2007 Oct;61(9):515-9. doi: 10.1016/j.biopha.2007.08.005. Epub 2007 Sep 14.
4
[Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China].
Zhongguo Fei Ai Za Zhi. 2005 Aug 20;8(4):274-8. doi: 10.3779/j.issn.1009-3419.2005.04.05.
5
The past, present and future of breast cancer research in China.
Cancer Lett. 2014 Aug 28;351(1):1-5. doi: 10.1016/j.canlet.2014.04.007. Epub 2014 Apr 13.
6
[Advanced research on circulating tumor cells in lung cancer].
Zhongguo Fei Ai Za Zhi. 2012 Nov;15(11):667-71. doi: 10.3779/j.issn.1009-3419.2012.11.03. Epub 2012 Oct 24.
7
Biomarkers in Lung Cancer.
Clin Chest Med. 2020 Mar;41(1):115-127. doi: 10.1016/j.ccm.2019.10.004. Epub 2020 Jan 2.
8
Biological markers in lung cancer: A clinician's perspective.
Cancer Biomark. 2010;6(3-4):123-35. doi: 10.3233/CBM-2009-0124.
9
The State of Lung Cancer Research: A Global Analysis.
J Thorac Oncol. 2016 Jul;11(7):1040-50. doi: 10.1016/j.jtho.2016.03.010. Epub 2016 Mar 21.
10
Biomarkers for the lung cancer diagnosis and their advances in proteomics.
BMB Rep. 2008 Sep 30;41(9):615-25. doi: 10.5483/bmbrep.2008.41.9.615.
引用本文的文献
1
Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer.
Genes Environ. 2023 Jul 1;45(1):21. doi: 10.1186/s41021-023-00278-1.
2
Physicochemical and Antioxidant Properties of the Degradations of Polysaccharides from and Their Suitable Molecular Weight Range on Inducing HeLa Cell Apoptosis.
Evid Based Complement Alternat Med. 2019 Aug 28;2019:4127360. doi: 10.1155/2019/4127360. eCollection 2019.
3
Biosynthesis, characterization, and anticancer effect of plant-mediated silver nanoparticles using .
Int J Nanomedicine. 2019 Mar 15;14:1969-1978. doi: 10.2147/IJN.S188235. eCollection 2019.
4
Jinfukang induces cellular apoptosis through activation of and in A549 cells.
Oncol Lett. 2018 Oct;16(4):4343-4352. doi: 10.3892/ol.2018.9149. Epub 2018 Jul 16.
5
microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.
Exp Ther Med. 2017 Jul;14(1):867-873. doi: 10.3892/etm.2017.4538. Epub 2017 Jun 1.
6
MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.
Int J Oncol. 2016 Oct;49(4):1325-33. doi: 10.3892/ijo.2016.3628. Epub 2016 Jul 25.
7
Transcriptome Profiling Reveals the Antitumor Mechanism of Polysaccharide from Marine Algae Gracilariopsis lemaneiformis.
PLoS One. 2016 Jun 29;11(6):e0158279. doi: 10.1371/journal.pone.0158279. eCollection 2016.
8
Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity.
Evid Based Complement Alternat Med. 2016;2016:7276161. doi: 10.1155/2016/7276161. Epub 2016 Mar 20.
9
Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer.
Thorac Cancer. 2014 Sep;5(5):425-30. doi: 10.1111/1759-7714.12113. Epub 2014 Aug 25.
10
Effect of edaravone on serum SP-A and arterial blood gas in patients with lobectomy.
Int J Clin Exp Med. 2015 Jun 15;8(6):10021-5. eCollection 2015.
本文引用的文献
1
Crizotinib in the treatment of non--small-cell lung cancer.
Clin Lung Cancer. 2013 Sep;14(5):473-80. doi: 10.1016/j.cllc.2013.04.006. Epub 2013 Jun 20.
2
Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer.
Oncol Lett. 2013 Apr;5(4):1211-1218. doi: 10.3892/ol.2013.1161. Epub 2013 Jan 29.
3
Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.
Thorac Surg Clin. 2013 May;23(2):211-24. doi: 10.1016/j.thorsurg.2013.01.002. Epub 2013 Feb 15.
4
Advances in cytopathology for lung cancer: the impact and challenges of new technologies.
Thorac Surg Clin. 2013 May;23(2):163-78. doi: 10.1016/j.thorsurg.2013.01.011. Epub 2013 Feb 15.
5
Lung cancer in China: challenges and interventions.
Chest. 2013 Apr;143(4):1117-1126. doi: 10.1378/chest.11-2948.
6
Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9.
7
Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer.
Future Oncol. 2013 Feb;9(2):167-77. doi: 10.2217/fon.12.198.
8
Lung cancer epigenetics: emerging biomarkers.
Biomark Med. 2013 Feb;7(1):49-58. doi: 10.2217/bmm.12.111.
9
Lymph node micrometastases detected by carcinoembryonic antigen mRNA affect long-term survival and disease-free interval in early-stage lung cancer patients.
Oncol Lett. 2012 Nov;4(5):1140-1144. doi: 10.3892/ol.2012.880. Epub 2012 Aug 24.
10
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.
Nat Genet. 2012 Dec;44(12):1330-5. doi: 10.1038/ng.2456. Epub 2012 Nov 11.
Zotero 插件